Page 465 - IJB-9-2
P. 465

International Journal of Bioprinting                                            Bioprinting of exosomes



               In  another  study,  therapeutic  growth  factors,   clinical applications . Moreover, as EXOs directly activate
                                                                               [72]
            vascular endothelial growth factor (VEGF), and bone   signaling processes to regulate cell function via the gene
            morphogenetic protein 2 (BMP2) were incorporated   transcription machinery, they act upstream of protein
            as spatiotemporally defined patterns in implants using   synthesis , and thus can be leveraged to modulate tissue
                                                                      [73]
            extrusion-based bioprinting for simultaneous induction of   repair  and  regeneration.  With  the  above  considerations,
            angiogenesis and osteogenesis . The results demonstrated   the 3DBP of cell-derived EXOs offers great potential
                                    [67]
            that implants with distinct spatial presentation of VEGF   in the engineering of implantable constructs for the
            promoted an increase in vessel invasion compared to   localized delivery of EXO-based therapeutics with precise
            implants that have been homogenously loaded with VEGF.   spatiotemporal control.
            Furthermore, bioprinted implants with both spatial VEGF   As a proof-of-concept model, EXOs have been
            gradients and defined BMP2 localization accelerated bone   incorporated in a bioink to engineer scaffolds with spatially
            defect healing with minimal heterotopic bone formation,   well-defined  patterns  for  promoting  cell  differentiation
            suggesting that spatiotemporally defined growth factor   in vitro . With regard to that, EXOs derived from different
                                                                    [74]
            delivery can be employed for the regeneration of large   macrophage subsets have been incorporated into scaffolds
            bone defects  in vivo. In a different study, extrusion-  fabricated via inkjet-based bioprinting, and their influence
            based 3D-printed scaffolds with physical (microgrooves)   on C2C12 mouse myoblasts has been investigated .
                                                                                                           [74]
            and biochemical (spatiotemporal gradients of nerve   In order to facilitate the bioprinting process, glycerol
            growth factor and glial cell line-derived neurotrophic   was used as an additive in the bioink to reduce EXO
            factor) cues were employed to provide axonal guidance   agglomeration, increase the viscosity of the bioink, and
            and   chemoattractant/chemokinetic  function  for  also serve as a humectant to reduce solvent evaporation
            neuroregeneration . In a rat model of nerve injury, the   at the tip of the nozzle. Cellular uptake studies showed
                           [68]
            3D-printed scaffolds facilitated nerve regeneration across a   that fluorescently labeled ECM-bound EXOs were readily
            10-mm nerve gap and demonstrated functional restoration   taken up by C2C12 cells within 15 min, suggesting that a
            of  the  regenerated  nerve  12  weeks  after  implantation   bioprinted solid-phase ECM  environment  did not  affect
            in vivo.                                           EXO membrane integrity for effective delivery of cargo
               Concurrently, these studies show the potential of 3DBP   into the cell cytoplasm. More importantly, ECM-bound
            as a promising methodology for spatiotemporal patterning   EXOs derived from proinflammatory M1 macrophages
            of growth factors, cell modulators, and therapeutic moieties   demonstrated spatial inhibition of myogenesis, whereas
            to tightly regulate tissue development for engineering   EXOs from pro-regenerative M2 macrophages promoted a
            complex functional tissues for tissue transplantation or   microenvironment that spatially induced myogenesis in a
            drug screening applications.                       dose-dependent manner in vitro. These results corroborate
                                                               the evidence showing the compatibility of 3DBP with
            4. Bioprinting of exosomes for regenerative        EXOs and the potential use of the spatially defined patterns
            therapy                                            of EXOs to spatially trigger intended biological functions.
            Although gradient patterning of growth factors offers   In another study, BMMSC EXOs were incorporated
            biomimetic path-specific biochemical cues for tightly   in a decellularized cartilage ECM/gelatin methacrylate
            regulated tissue regeneration, the supraphysiological   bioink and 3D printed using the dynamic projection
            release of protein therapeutics has been shown to induce   stereolithography technique to yield EXO-functionalized
            adverse effects without significant therapeutic benefits.   scaffolds . The final bioprinted structure, which
                                                                      [75]
            For  instance,  major  adverse  events  such  as  heterotopic   possessed radially oriented channels to promote cartilage
            ossification, osteolysis, infection, and cancer have been   repair and regeneration, was crosslinked in the presence
            implicated with INFUSE® bone graft, which consists of a   of a photoinitiator, lithium acylphosphinate, and 405-nm
                                                                                   [75]
            Col sponge, loaded with recombinant human BMP2 [69,70] .   wavelength  visible  light .  Subsequent  implantation  of
            Alternatively, directional gradient release of EXOs at the   these scaffolds in a rabbit osteochondral defect model
            target site can be availed to modulate tissue regeneration   demonstrated that the EXOs released from the bioprinted
            and function. The advantages of employing EXOs over   scaffolds rescued cartilage mitochondrial dysfunction,
            recombinant therapeutic growth factor (GF) proteins are   promoted chondrocyte migration, and supported
            multifold. As EXOs are naturally produced in the body,   M2 macrophage polarization, thereby facilitating the
                                                                                         [75]
            they possess unique membrane proteins that facilitate   regeneration of cartilage  in vivo . Although this study
            the internalization by recipient cells . Furthermore, as   did not aim to spatially distribute EXOs in the bioprinted
                                          [71]
            EXOs are native to the body, they are associated with low   structure, it provided evidence  that the 3DBP  of  cell-
            immune responses and thus safe even at high dosages for   derived EXOs can be used for tissue regeneration.

            Volume 9 Issue 2 (2023)                        457                          https://doi.org/10.18063/ijb.690
   460   461   462   463   464   465   466   467   468   469   470